Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease
This study has been completed.
Sponsor:
Mayo Clinic
Information provided by (Responsible Party):
Roberto P. Benzo, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01583595
First received: February 7, 2012
Last updated: April 1, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Most patients with chronic lung disease underestimate their actual walking ability due to low confidence. To better understand the relationships between lung function, self-efficacy for walking (confidence in ability to walk a defined distance), actual walking ability for the same distance gait speed and physical activity level-PAL- (total energy expenditure/resting metabolic rate).
Quality of life, self efficacy for activity questionnaires, physical activity level measurement, 4-meter gait speed and 6-minute walk distance will be measured.
| Condition |
|---|
|
Chronic Lung Disease Self-efficacy |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Determining the Relationships Between Self-efficacy for Walking Ability, Gate Speed and Physical Activity in Patients With Chronic Lung Disease |
Resource links provided by NLM:
Further study details as provided by Mayo Clinic:
Primary Outcome Measures:
- Analyze associations between self-efficacy for walking, gait speed, physical activity level and perceptions of symptoms in patient with chronic lung disease (COPD and Pulmonary Fibrosis) [ Time Frame: Day of enrollment. ] [ Designated as safety issue: No ]Correlation , regression models and mediation analysis (self efficacy and physical activity) will be performed.
Secondary Outcome Measures:
- Predictive utility of 4-meter gait speed for estimating physical activity level (PAL) as validated by gold standard activity monitor. [ Time Frame: 1 week ] [ Designated as safety issue: No ]Measure 4-meter gait speed during standardized 6 mintute walk test and compare to armband activity monitor results to determine predictive ability, if any, on PAL in people with chronic lung disease.
| Enrollment: | 70 |
| Study Start Date: | December 2011 |
| Study Completion Date: | July 2012 |
| Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 40 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Adults with chronic lung disease
Criteria
Inclusion Criteria:
- Men and women 40 years and older
- Diagnosis of any chronic lung disease as evidenced by pulmonary function testing completed within the prior 12 months
- Able to walk independently and successfully complete the 6-minute walk assessment
Exclusion Criteria:
- Unable to walk without assistance or complete the 6-minute walk assessment
- Patients unable to comprehend and accurately respond to the study questionnaires either by written or spoken communication
- Patients diagnosed with or treated for a lower respiratory tract infection or COPD exacerbation within the prior 30 days
Contacts and Locations More Information
No publications provided
| Responsible Party: | Roberto P. Benzo, Consultant Pulmonary and Critical Care Medicine, Mayo Clinic |
| ClinicalTrials.gov Identifier: | NCT01583595 History of Changes |
| Other Study ID Numbers: | 11-008157 |
| Study First Received: | February 7, 2012 |
| Last Updated: | April 1, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Mayo Clinic:
|
Chronic Lung Disease Exercise Self-efficacy |
Additional relevant MeSH terms:
|
Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on June 18, 2013